ATYR PHARMA INC - COM (LIFE)

CUSIP: 002120103

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM
Total 13F shares
11,348,232
Share change
-1,949,817
Total reported value
$9,219,875
Price per share
$0.81
Number of holders
28
Value change
-$1,830,799
Number of buys
10
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 002120103?
CUSIP 002120103 identifies LIFE - ATYR PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ATYR PHARMA INC - COM (LIFE) as of Q3 2018

As of 30 Sep 2018, ATYR PHARMA INC - COM (LIFE) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,348,232 shares. The largest 10 holders included FMR LLC, Polaris Venture Management Co. V, L.L.C., Viking Global Investors LP, RENAISSANCE TECHNOLOGIES LLC, Vanguard Group Inc, Artal Group S.A., BlackRock Inc., Glen Harbor Capital Management LLC, Meadow Creek Investment Management LLC, and ACADIAN ASSET MANAGEMENT LLC. This page lists 28 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.